|
EXOSC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.381410E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.365240E-01 |
| Normal-vs-Stage2 |
1.048550E-01 |
| Normal-vs-Stage3 |
2.532000E-01 |
| Normal-vs-Stage4 |
7.358000E-01 |
| Stage1-vs-Stage2 |
6.957000E-01 |
| Stage1-vs-Stage3 |
7.330200E-01 |
| Stage1-vs-Stage4 |
1.259220E-01 |
| Stage2-vs-Stage3 |
5.031600E-01 |
| Stage2-vs-Stage4 |
9.680000E-02 |
| Stage3-vs-Stage4 |
2.114200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.695700E-02 |
| Normal-vs-AfricanAmerican |
6.919600E-02 |
| Normal-vs-Asian |
5.222000E-01 |
| Caucasian-vs-AfricanAmerican |
1.582140E-03 |
| Caucasian-vs-Asian |
4.419200E-01 |
| AfricanAmerican-vs-Asian |
7.421200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.577230E-01 |
| Normal-vs-Female |
2.565200E-01 |
| Male-vs-Female |
6.453000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.577200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.675500E-03 |
| Normal-vs-Age(61-80Yrs) |
7.251800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.995000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.472200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.085200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.982400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.003900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.281900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.769400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.617800E-02 |
| Normal-vs-Grade 2 |
1.750810E-01 |
| Normal-vs-Grade 3 |
6.376100E-02 |
| Normal-vs-Grade 4 |
2.624200E-01 |
| Grade 1-vs-Grade 2 |
3.109800E-01 |
| Grade 1-vs-Grade 3 |
3.670400E-01 |
| Grade 1-vs-Grade 4 |
1.562090E-02 |
| Grade 2-vs-Grade 3 |
9.974800E-01 |
| Grade 2-vs-Grade 4 |
4.291600E-02 |
| Grade 3-vs-Grade 4 |
1.841650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.88569999995492E-06 |
| Normal-vs-ccB subtype |
6.095900E-02 |
| ccA subtype-vs-ccB subtype |
1.174480E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.342840E-01 |
| Normal-vs-N1 |
3.776200E-01 |
| N0-vs-N1 |
2.371800E-01 |
|
|
